Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection.
about
Influenza virus antigenic variation, host antibody production and new approach to control epidemicsSystemic delivery of oncolytic viruses: hopes and hurdlesNatural antibody and complement mediate neutralization of influenza virus in the absence of prior immunityComplement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced diseaseAn AGM model for changes in complement during pregnancy: neutralization of influenza virus by serum is diminished in late third trimesterModeling host genetic regulation of influenza pathogenesis in the collaborative crossComplement activation is required for induction of a protective antibody response against West Nile virus infectionWest Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor HProtective immune responses against West Nile virus are primed by distinct complement activation pathwaysInnate immunity to influenza virus: implications for future therapyComplement and its role in protection and pathogenesis of flavivirus infectionsEvasion of innate and adaptive immunity by flavivirusesInfections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyComplement: a key system for immune surveillance and homeostasisInnate and adaptive immunologic functions of complement in the host response to Listeria monocytogenes infection.Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.Genomic profiling of tumor necrosis factor alpha (TNF-alpha) receptor and interleukin-1 receptor knockout mice reveals a link between TNF-alpha signaling and increased severity of 1918 pandemic influenza virus infection.Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection.A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infectionThe innate immunity of guinea pigs against highly pathogenic avian influenza virus infectionViral infection of the lung: host response and sequelaeComplement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury.Surviving mousepox infection requires the complement systemC3d regulates immune checkpoint blockade and enhances antitumor immunity.Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs.Role and mechanism of action of complement in regulating T cell immunity.Complement and viral pathogenesisImmunogenicity to biologics: mechanisms, prediction and reduction.Targeting viral antigens to CD11c on dendritic cells induces retrovirus-specific T cell responsesA new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.Complement mediated signaling on pulmonary CD103(+) dendritic cells is critical for their migratory function in response to influenza infection.Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.Intranasal peptide-induced tolerance and linked suppression: consequences of complement deficiencyThe herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo.The Vaccinia virus complement control protein modulates adaptive immune responses during infectionLocally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells.Impaired CD8(+) T cell immunity after allogeneic bone marrow transplantation leads to persistent and severe respiratory viral infection.Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenzaC3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cellsComplement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection.
P2860
Q21245119-30A5D88B-7502-4B8D-9883-3C4EF65B907BQ21284969-F31F5C4A-27AB-45E3-AF9F-D9847D432B24Q24672388-7817E2EB-BA3D-480B-83C4-815E68091073Q24682922-6174FB4B-7DAC-47EE-9B6B-E39E5DA99337Q27326934-406463BC-0131-4BDA-826B-72A92DD187C9Q27336134-71E955E4-CA74-4C93-9E64-540A758E0833Q27469834-C3E4F764-4BDC-4399-BBB7-B5EE5B1A88C3Q27477691-089052B9-7AC3-4C13-B441-06D839EC5B48Q27482651-24580BA3-D7BA-4DB2-93D3-7FFB2D3F4172Q27489605-975C5E20-85A7-4BD1-94D0-AED4BE643129Q27490236-FAC345BE-E150-4930-BB62-F30AB1AE4DAAQ28204656-3CB114C7-408F-45F1-A647-AF7DD4CCF699Q28972389-E7F51537-2847-429C-B0A2-A87E9B604D2CQ29615484-FE11ECB7-AB3F-4E13-BA39-26546818E1A9Q30244210-6811C94E-2278-40C4-BC06-92BF9EDA54ECQ30386279-7CA42B2A-BD0D-446B-B427-7FD3977DEFEAQ30394612-9F4D5844-69E8-4E25-9B15-BAEB71F83FCDQ30399993-5D0EB334-C7E0-4024-B652-CEE86C916465Q30400787-63B856A3-568A-41E5-A6EE-0CCF8A232A61Q30401156-E0D8D201-E0A0-4E53-8AD6-70A677A17043Q30409296-6FDB1175-2B90-41E2-B551-B49D13167181Q30430891-C3366F4B-ECD6-4924-8D3E-6A9CD6512764Q33396210-37CD6800-5D4B-441E-A079-F5BA34F30C02Q33631081-8FAB8277-97BA-4A9D-BA7E-96CDF280B243Q33818860-B2EC28F3-1E83-43AF-88B8-4C4591AF739DQ34072846-BC25C5C6-BC5C-4FD4-9DB3-6650CC08B387Q34162421-536FE60A-7A45-4EA9-ABB2-84CF5DCEDA9FQ34296526-3C2A9B89-9140-4479-9622-592FFBA13F0CQ34428096-0EDF3723-26FA-49DD-81B2-1841670B7640Q34494082-0EA81E46-B021-4DAE-8C80-CE3B5744B2E1Q34550742-F176E46A-19D6-4E94-9620-04546353E4FEQ34629133-BC76B4D6-9C2C-4D29-B9B7-1A5E947AB8BEQ34691304-29FA91B2-B986-4754-BA8E-644C9D3CE1D7Q34742635-96CA0021-5D3D-43C8-9D37-70CEAB2363CFQ34742926-392D4C6B-11C2-4872-B6E2-54FFA6959725Q34760201-3623A345-8D5A-48E2-86C3-31676A6997C8Q34779037-0F7AA27C-E076-40A9-8AD6-D07B6BACCDDAQ35023393-395709E1-972F-41F4-A741-3A049D8886A8Q35071379-78A3D6CD-CD9B-48E3-845E-44CAE96671BDQ35167918-15EF15F0-DA68-463D-A1CE-ABE77DC4C735
P2860
Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Complement component C3 promot ...... ute influenza virus infection.
@en
Complement component C3 promot ...... ute influenza virus infection.
@nl
type
label
Complement component C3 promot ...... ute influenza virus infection.
@en
Complement component C3 promot ...... ute influenza virus infection.
@nl
prefLabel
Complement component C3 promot ...... ute influenza virus infection.
@en
Complement component C3 promot ...... ute influenza virus infection.
@nl
P2093
P2860
P356
P1433
P1476
Complement component C3 promot ...... ute influenza virus infection.
@en
P2093
Brian Abel
Martin F Bachmann
Michael Carroll
P2860
P2888
P304
P356
10.1038/NM0402-373
P407
P577
2002-04-01T00:00:00Z
P6179
1002897348